genome & trait engineering, gene & cell-based therapy, synthetic & systems biology, GMOs, etc.

Seattle
Joined August 2012
Happy to be able to announce that Demetrix wrapped up our Series A. I'm hoping to spend a little less time with zoom and more time with data and #fsharp. finance.yahoo.com/news/demet…
5
5
1
14
GenomeEngineer retweeted
This Post is from an account that no longer exists. Learn more
1
1
GenomeEngineer retweeted
Ceiling on #SpinalMuscularAtrophy #GeneTherapy cost-effectiveness? Keying off different #QALY values, @ICER_Review sees $900K, @Novartis sees $5M, while others like @PioneerBoston argue against QALY approach buff.ly/2GMv447 @ReutersDeenaB @Reuters @STATnews via @DailyScan
GenomeEngineer retweeted
My latest blog post is out: BIOMEDICAL ETHICS: MORAL DILEMMAS WITH LIVES IN THE BALANCE. With all the media emphasis on dealmaking in biopharma, ethical considerations often get pushed to the background. Lots of unresolved issues that need to be discussed: lymanbiopharma.com/page43/bl…
RT @GenomeCanada: Request for Applications: Genomics in Society Interdisciplinary Research Teams bit.ly/GC_GISIRT #Genomics #LivingInnovation
3
2
GenomeEngineer retweeted
Green light from @USDA for unregulated growth in the field for transgenic gossypol-free (in seeds) cotton developed @TAMU. Reduction in toxicity a potential boon for nutritional use, subject to future @US_FDA approval. buff.ly/2ExvwmC @nprDanCharles @NPR @CottonInc
GenomeEngineer retweeted
#Mesa18 on #GeneTherapy: The cost to "bend the curve of life"? The value of bending the curve of life? How will patients, providers, payers & pharma answer? buff.ly/2OdSh3w @SanDiegoScience @SDUT @NovartisCancer @Spark_Tx via @DailyScan
An extensive review concludes that GMO is less disruptive of crop genetics than conventional breeding, so the huge rigorous evaluations & regulations are not justified by any scientific evidence of safety risk, simply a waste of time & money! @mark_lynas allianceforscience.cornell.e…
3
75
3
118
GenomeEngineer retweeted
Engineering arboreal heritage: GMO American chestnut technology is ready to spread, but regulatory row remains to be hoed buff.ly/2wnDibY @GabrielPopkin @ScienceMagazine @SUNYESF @EnvDefenseFund @ChestnutPowell @Chestnut1904 @USDAFoodSafety @USDA @ForestService
1
1
GenomeEngineer retweeted
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
2
3
GenomeEngineer retweeted
Surprising discovery today: there are only 9 live U.S. trademarks incorporating the word “CRISPR”. 😲 If you want to protect use in commerce of your favorite CRISPR phrase before someone else does, please feel free to contact me. @ipmvs #CRISPR #geneediting
1
3
1
3
GenomeEngineer retweeted
first U.S. facility for commercial production of AquAdvantage #GMO salmon: @AquaBountyTech announces @US_FDA site approval buff.ly/2r5x2Cj $XON $AQB @Intrexon
2
2
GenomeEngineer retweeted
#GeneTherapy for #BetaThalassemia: @BluebirdBio treatment is better than before, but not yet perfect, if "perfect" = "most serious form cured with 1 treatment" buff.ly/2HeWFaZ @LurieChildrens @JohnCendpts @EndPts $BLUE @NEJM via @RobSteinNews @NPR @Groopman @NewYorker
1
1
GenomeEngineer retweeted
Articles, including a focus on #GenomeEngineering and #GeneEditing, on more effective communication -- listening to and understanding as well transmitting to and informing -- with the public about science buff.ly/2HWS3WE #SynBio @Chung_Jibum @SBurall @SJasanoff
2
2
GenomeEngineer retweeted
DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead - Blog - IAM - Informing IP value bit.ly/2Euhmya